ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium
6.12.2024 12:30:00 CET | ACCESS Newswire | Press release
TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium.
PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer.
ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on these findings as well as earlier in vivo efficacy studies, ProteinQure has initiated GLP-toxicology studies for PQ203 in support of an anticipated investigational new drug application filing in Q2 of 2025.
"These combined findings confirm the power of our computational drug design platform and its potential to address key challenges in cancer therapy. We are deeply committed to moving PQ203 forward and are eager to bring this innovative treatment to clinical trials." stated Lucas Siow, CEO of ProteinQure.
Phase 1a/b trial initiation for PQ203 is planned for the second half of 2025 and will be coordinated at the Princess Margaret Cancer Center in Toronto and other leading hospitals in North America.
For media inquiries please contact Lucas Siow at lucas@proteinqure.com
SOUCE: ProteinQure Inc.
View the original press release on accesswire.com
ProteinQure Inc.
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Schedules Conference Call to Discuss First Quarter 2026 Financial Results on Friday, May 15, 202630.4.2026 21:00:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / April 30, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset ("RWA") tokenization technologies, today announced that it will report financial results for its first quarter of 2026 prior to market open on Friday, May 15, 2026. Following the release, Datavault AI will host a conference call and live webcast on the same day, at 8:30 a.m. ET. Conference Call and Webcast Information Date: Friday, May 15, 2026, at 8:30 a.m. ET Participant Dial-in (US): 1-877-709-8150 Participant Dial-in (International): 1-201-689-8354 -- or Click HERE for participant International Toll-Free access numbers Webcast Access: Click Here Datavault AI CEO, Nathaniel Bradley, and CFO Brett Moyer, will be presenting. A replay of the webcast will be made available later in the day in the Investors/Presentations section of the Datavault AI website: Click Here About Datavau
POLARIS Laboratories Expands Globally with Acquisition of UK-Based Oil Check Laboratory Services30.4.2026 20:42:00 CEST | Press release
POLARIS Laboratories® acquires Oil Check Laboratory Services LTD (OCLS), a strategic step in supporting growing industries, markets and key global customers. INDIANAPOLIS, IN / ACCESS Newswire / April 30, 2026 / POLARIS Laboratories® announces the acquisition of Oil Check Laboratory Services Ltd (OCLS), a well-established fluid analysis laboratory headquartered in Doncaster, United Kingdom. The transaction represents a strategic step in POLARIS Laboratories' expansion into supporting new markets including data centers, power generation and transformer oils, enhancing its international presence and strengthening its ability to serve customers across key global markets. OCLS is recognized for its high-quality lubricant and diesel fuel testing, as well as condition monitoring services, supporting a diverse base of industrial and mobile equipment applications. The combination of companies brings together complementary technical capabilities, increased testing capacity, and an expanded regi
OMP Ranked in Highest Two Across All Four Use Cases in the 2026 Gartner(R) Critical Capabilities for Supply Chain Planning Solutions: Process Industries30.4.2026 15:00:00 CEST | Press release
ANTWERPEN, BE / ACCESS Newswire / April 30, 2026 / OMP, a leading provider of AI-powered supply chain planning, has been ranked in highest two across all four Use Cases in the 2026 Gartner® Critical Capabilities for Supply Chain Planning Solutions report for process industries. This report, a companion to the Gartner® Magic Quadrant™, evaluates 16 vendors on Critical Capabilities and real-world Use Cases, helping organizations assess how well solutions support different levels of supply chain planning maturity. This recognition follows OMP's recent position as highest in Ability to Execute and furthest in Completeness of Vision in the 2026 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions: Process Industries. Get the full Gartner® Critical Capabilities report. Consistent strength in real-world planning Use Cases The critical capabilities that most distinguish supply chain planning (SCP) vendors for process industries from each other in 2026 are AI-driven planning and decisio
Karbon-X Advances Sur del Meta REDD+ Project with Biodiversity Partnership30.4.2026 15:00:00 CEST | Press release
Collaboration supports the use of ecological data in project design as demand for high-integrity carbon credits accelerates. CALGARY, AB / ACCESS Newswire / April 30, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions provider operating across compliance and voluntary carbon markets, today announced the formalization of a strategic partnership with Fundación BioHerencia, a participating landowner of the REDD+ project Sur del Meta currently being implemented in Colombia. The partnership aims to embed biodiversity conservation within the REDD+ project by combining the landowner's conservation expertise with community-based monitoring efforts. The agreement establishes a technical, scientific, and operational framework to support the integration of field-based ecological data into the project's Measurement, Reporting, and Verification (MRV) systems. As a participating landowner within the REDD+ project, BioHerencia owns Harpy Eagle
Datavault AI and Kings Mine Capital Agree to Establish $150 Million+ GoldVault(TM) Tokenization Program30.4.2026 15:00:00 CEST | Press release
Agreement Contemplates Bullion at $3,000 an Ounce to Spot for 24-Month Delivery with $40 Million Projected Profit at $5000 an Ounce. GoldVault™ Tokens Issue at Discount to Spot with Production-Linked Royalty Stream PHILADELPHIA, PA / ACCESS Newswire / April 30, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, and King Mining Capital ("King Mining Capital") today announced that they have entered into a agreement for a multi-component strategic transaction that will combine a Datavault AI equity investment in King Mining Capital, a Datavault AI stock-funded purchase of 20,000 ounces of physical gold bullion, and the launch of a $150 million-plus GoldVault™ tokenization program backed by King Mining Capital's high-grade gold resources. Direct Equity, Physical Bullion, and Stock-Funded Consideration Subject to entering into a definitive agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom